Bibliografía del artículo
1. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127(4):1239-55, 2004.
2. Patti MG, Gorodner MV, Galvani C et al. Spectrum of esophageal motility disorders: implications for diagnosis and treatment. Arch Surg 140(5):442-8, 2005.
3. Bennett J. ABC of the upper gastrointestinal tract. Oesophagus: atypical chest pain and motility disorders. BMJ 323(7316):791-4, 2001.
4. Bercik P, De Giorgio R, Blennerhassett P, Verdu EF, Barbara G, Collins SM. Immune-mediated neural dysfunction in a murine model of chronic
Helicobacter pylori infection. Gastroenterology 123(4):1205-15, 2002.
5. Budzynski J, Klopocka M, Bujak R, Swiatkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in
Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 16(5):451-7, 2004.
6. Vizi ES, Elenkov IJ. Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 53(1-2):229-244, 2002.
7. Gulcelik NE, Kaya E, Demirbas B et al.
Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 28(3):214-7, 2005.
8. Swiatkowski M, Budzynski J, Klopocka M, Ziolkowski M, Bujak R, Sinkiewicz W. Parameters of the functional and morphological status of the upper digestive tract in alcohol-dependent male patients with depression and alexithymia in the context of autonomic nervous system activity and nitric oxide plasma level. Med Sci Monit 10(2):CR68-74, 2004.
9. Wilhelmsen I, Berstad A. Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve-year follow-up. Scand J Gastroenterol 39(8):717-21, 2004.
10. Rossetto O, De Bernard M, Pellizzari R et al. Bacterial toxins with intracellular protease activity. Clin Chim Acta 291(2):189-99, 2000.
11. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123(3):716-24, 2003.
12. Yagci M, Yamac K, Acar K, Cingi E, Kitapci M, Haznedar R. Gastric emptying in patients with vitamin B(12) deficiency. Eur J Nucl Med Mol Imaging 29(9):1125-7, 2002.
13. Kutluana U, Simsek I, Akarsu M, Kupelioglu A, Karasu S, Altekin E. Is there a possible relation between atrophic gastritis and premature atherosclerosis? Helicobacter 10(6):623-9, 2005.
14. Katoh K, Nomura M, Nakaya Y. et al. Autonomic nervous activity before and after eradication of
Helicobacter pylori in patients with chronic duodenal ulcer. Aliment Pharmacol Ther 16(Suppl 2):180-6, 2002.
15. Nada T, Nomura M, Iga A. et al. Autonomic nervous function in patients with peptic ulcer studied by spectral analysis of heart rate variability. J Med 32(5-6):333-47, 2001.
16. Nomura M, Yukinaka M, Miyajima H. et al. Is autonomic dysfunction a necessary condition for chronic peptic ulcer formation? Aliment Pharmacol Ther 14(Suppl 1):82-6, 2000.
17. Lucini D, Cerchiello M, Basilisco G. et al. Autonomic control of heart period in duodenal ulcer patients: insights from spectral analysis of heart rate variability. Auton Neurosci 84(3):122-129, 2000.
18. Yukinaka M, Nomura M, Saijyo T et al. Evaluation of autonomic nervous function in patients with essential hypertension complicated with peptic ulcer. J Gastroenterol Hepatol 15(1):40-44, 2000.
19. Tougas G, Spaziani R, Hollerbach S et al. Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain. Gut 49(5):706-12, 2001.
20. Pirtniecks A, Smith LF, Thorpe JA. Autonomic dysfunction in non-specific disorders of oesophageal motility. Eur J Cardiothorac Surg 17(2):101-5, 2000.
22. Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 54(10):1396-401, 2005.
23. Willich SN, Kulig M, Muller-Nordhorn J. European survey on circadian variation of angina pectoris (ESCVA) in treated patients. Herz 29(7):665-72, 2004.
24. D'Negri CE, Marelich L, Vigo D et al. Circadian periodicity of heart rate variability in hospitalized angor patients. Clin Auton Res 15(3):223-32, 2005.
25. Kawano H, Ogawa H. Endothelial function and coronary spastic angina. Internal Medicine 44(2):91-99, 2005.
26. Dobrzycki S, Baniukiewicz A, Korecki J et al. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD? Int J Cardiol 104(1):67-72, 2005.
27. Dobrzycki S, Skrodzka D, Musial WJ et al. Relationship between gastroesophageal reflux disease and myocardial ischemia. Effect of reflux on temporary activity of autonomic nervous system. Rocz Akad Med Bialymst 49:93-7, 2004.
28. Swiatkowski M, Budzynski J, Klopocka M, Pulkowski G, Suppan K, Fabisiak J, Morawski W, Majer M. Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. Med Sci Monit 10(9):CR524-529, 2004.
29. Johansson S, Wallander MA, Ruigomez A, Garcia Rodriguez LA. Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs? Aliment Pharmacol Ther 18(10):973-8, 2003.
30. Laheij RJ, Van Rossum LG, Jansen JB, Verheugt FW. Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial. Aliment Pharmacol Ther 18(1):109-15, 2003.
31. Chauhan A, Petch MC, Schofield PM. Cardio-oesophageal reflex in humans as a mechanism for 'linked angina'. Eur Heart J 17(3):407-413, 1996.
32. Caldwell MT, Byrne PJ, Marks P, Walsh TN, Hennessy TP. Bradykinin, coronary artery disease and gastro-oesophageal reflux. Br J Surg 81(10):1462-4, 1994.
33. Budzynski J, Swiatkowski M, Klopocka M, Fabisiak J, Bujak R, Sinkiewicz W. Relationship between results of electrocardiographic exercise tests and intraesophageal pH in men with atypical chest pain. Pol Arch Med Wewn 103:135-140, 2000.
34. Makk LJ, Leesar M, Joseph A, Prince CP, Wright RA. Cardioesophageal reflexes: an invasive human study. Dig Dis Sci 45(12):2451-4, 2000.
35. Lee YC, Wang HP, Lin LY. et al. Heart rate variability in patients with different manifestations of gastroesophageal reflux disease. Auton Neurosci 116(1-2):39-45, 2004.
36. Chen CL, Orr WC. Autonomic responses to heartburn induced by esophageal acid infusion. J Gastroenterol Hepatol 19(8):922-6, 2004.
37. Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol 20(3):332-9, 2005.
38. Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol 15(1):72-7, 1990.
38. Bass C, Mayou R. ABC of psychological medicine. Chest Pain BMJ 325:588-591, 2002.
39. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA 293(4):477-84, 2005.
40. Katerndahl D. Panic & plaques: panic disorder & coronary artery disease in patients with chest pain. J Am Board Farm Pract 17(2):114-26, 2004.
41. Tsai SH, Chen CM, Chang CS, Chen GH. Effect of
Helicobacter pylori infection on intragastric acidity in patients with reflux esophagitis. J Gastroenterol 39(9):821-6, 2004.
42. Giral A, Celikel CA, Ozdogan O, Tozun N, Ulusoy NB, Kalayci C. Impact of
Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. J Gastroenterol Hepatol 20(12):1886-91, 2005.
43. Ando T, El-Omar EM, Goto Y et al. IL-1 beta pro-inflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2005.
44. Delaney B, McColl K. Review article:
Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 22(Suppl 1):32-40, 2005.
45. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis 18(1):20-6, 2000.
46. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain- a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 19(10):1123-30, 2004.
47. Dickman R, Emmons S, Cui H et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 22(6):547-55, 2005.
48. Zerbib F, Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP.
H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans. Am J Physiol Gastrointest Liver Physiol 281(2):G350-6, 2001.
49. Tanaka I, Tatsumi Y, Kodama T et al. Effect of
Helicobacter pylori eradication on gastroesophageal function. J Gastroenterol Hepatol 19(3):251-7, 2004.
50. Spence JD, Norris J. Infection, inflammation, and atherosclerosis. Stroke 34(2):333-4, 2003.
51. Kowalski M.
Helicobacter pylori infection in coronary artery disease: influence of
H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of
H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52(1 Suppl 1):3-31, 2001.
52. Kaplan M, Yavuz SS, Cinar B et al. Detection of
Chlamydia pneumoniae and
Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2005.
53. Oshima T, Ozono R, Yano Y. et al. Association of
Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. Am Coll Cardiol 45(8):1219-22, 2005.
54. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does eradication of
Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50(7):1228-31, 2005.
55. Migneco A, Ojetti V, Specchia L. et al. Eradication of
Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 8(6):585-9, 2003.
56. Cassar K, Bachoo P, Ford I, McGee M, Greaves M, Brittenden J.
Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication. J Vasc Surg 39(3):560-4, 2004.
57. Colucci M, Rossiello MR, Pentimone A et al. Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with
Helicobacter pylori infection. Thromb Res 116(6):471-7, 2005.
58. Aydemir S, Bayraktaroglu T, Sert M et al. The effect of
Helicobacter pylori on insulin resistance. Dig Dis Sci 50(11):2090-3, 2005.
59. Kratnov AE, Pavlov ON.
Helicobacter pylori infection and state of antioxidant protection in patients with the unstable course of ischemic disease. Eksp Klin Gastroenterol 5(4-9):145, 2004.
60. Montenero AS, Mollichelli N, Zumbo F. et al.
Helicobacter pylori and atrial fibrillation: a possible pathogenic link. Heart 91(7):960-1, 2005.
61. Whittle BJ, Morschl E, Pozsar J, Moran AP, Laszlo F.
Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac, hepatic, renal and pulmonary tissues. J Physiol Paris 95(1-6):257-9, 2001.